Bank of New York Mellon’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-688
| Closed | -$4.63K | – | 4342 |
|
|
2023
Q4 | $4.63K | Hold |
688
| – | – | ﹤0.01% | 4284 |
|
|
2023
Q3 | $6.3K | Sell |
688
-969
| -58% | -$8.87K | ﹤0.01% | 4313 |
|
|
2023
Q2 | $35K | Sell |
1,657
-3,752
| -69% | -$79.3K | ﹤0.01% | 4214 |
|
|
2023
Q1 | $146K | Buy |
5,409
+922
| +21% | +$24.8K | ﹤0.01% | 4004 |
|
|
2022
Q4 | $159K | Sell |
4,487
-111
| -2% | -$3.93K | ﹤0.01% | 4034 |
|
|
2022
Q3 | $1.04M | Buy |
4,598
+689
| +18% | +$156K | ﹤0.01% | 3184 |
|
|
2022
Q2 | $739K | Sell |
3,909
-128
| -3% | -$24.2K | ﹤0.01% | 3351 |
|
|
2022
Q1 | $1.01M | Sell |
4,037
-183
| -4% | -$45.6K | ﹤0.01% | 3313 |
|
|
2021
Q4 | $656K | Buy |
4,220
+58
| +1% | +$9.02K | ﹤0.01% | 3628 |
|
|
2021
Q3 | $833K | Buy |
4,162
+313
| +8% | +$62.6K | ﹤0.01% | 3498 |
|
|
2021
Q2 | $984K | Buy |
3,849
+387
| +11% | +$98.9K | ﹤0.01% | 3430 |
|
|
2021
Q1 | $919K | Sell |
3,462
-21
| -0.6% | -$5.58K | ﹤0.01% | 3377 |
|
|
2020
Q4 | $1.28M | Buy |
3,483
+337
| +11% | +$124K | ﹤0.01% | 3110 |
|
|
2020
Q3 | $768K | Buy |
3,146
+92
| +3% | +$22.5K | ﹤0.01% | 3269 |
|
|
2020
Q2 | $879K | Buy |
3,054
+495
| +19% | +$142K | ﹤0.01% | 3180 |
|
|
2020
Q1 | $522K | Buy |
2,559
+23
| +0.9% | +$4.69K | ﹤0.01% | 3341 |
|
|
2019
Q4 | $1.13M | Buy |
2,536
+64
| +3% | +$28.6K | ﹤0.01% | 3174 |
|
|
2019
Q3 | $761K | Buy |
2,472
+48
| +2% | +$14.8K | ﹤0.01% | 3314 |
|
|
2019
Q2 | $770K | Buy |
2,424
+1,641
| +210% | +$521K | ﹤0.01% | 3369 |
|
|
2019
Q1 | $329K | Buy |
783
+126
| +19% | +$52.9K | ﹤0.01% | 3715 |
|
|
2018
Q4 | $200K | Sell |
657
-7
| -1% | -$2.13K | ﹤0.01% | 3851 |
|
|
2018
Q3 | $239K | Sell |
664
-16
| -2% | -$5.76K | ﹤0.01% | 3874 |
|
|
2018
Q2 | $249K | Buy |
680
+183
| +37% | +$67K | ﹤0.01% | 3867 |
|
|
2018
Q1 | $147K | Buy |
497
+22
| +5% | +$6.51K | ﹤0.01% | 3980 |
|
|
2017
Q4 | $199K | Sell |
475
-11
| -2% | -$4.61K | ﹤0.01% | 3940 |
|
|
2017
Q3 | $160K | Hold |
486
| – | – | ﹤0.01% | 3918 |
|
|
2017
Q2 | $115K | Buy |
486
+29
| +6% | +$6.86K | ﹤0.01% | 3998 |
|
|
2017
Q1 | $157K | Buy |
457
+21
| +5% | +$7.21K | ﹤0.01% | 3933 |
|
|
2016
Q4 | $152K | Buy |
436
+25
| +6% | +$8.72K | ﹤0.01% | 3953 |
|
|
2016
Q3 | $165K | Buy |
411
+52
| +14% | +$20.9K | ﹤0.01% | 3934 |
|
|
2016
Q2 | $214K | Buy |
+359
| New | +$214K | ﹤0.01% | 3875 |
|
|
2016
Q1 | – | Sell |
-138
| Closed | -$91K | – | 4272 |
|
|
2015
Q4 | $91K | Hold |
138
| – | – | ﹤0.01% | 4055 |
|
|
2015
Q3 | $65K | Hold |
138
| – | – | ﹤0.01% | 4158 |
|
|
2015
Q2 | $78K | Sell |
138
-33
| -19% | -$18.7K | ﹤0.01% | 4085 |
|
|
2015
Q1 | $1.46M | Buy |
171
+37
| +28% | +$316K | ﹤0.01% | 3078 |
|
|
2014
Q4 | $1.17M | Buy |
134
+12
| +10% | +$105K | ﹤0.01% | 3209 |
|
|
2014
Q3 | $573K | Hold |
122
| – | – | ﹤0.01% | 3572 |
|
|
2014
Q2 | $879K | Buy |
122
+90
| +281% | +$648K | ﹤0.01% | 3386 |
|
|
2014
Q1 | $170K | Buy |
+32
| New | +$170K | ﹤0.01% | 3869 |
|